- Home
- WT vs RGC Comparison
WT vs RGC Comparison
Compare WT & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | WT | RGC |
|---|---|---|
| Founded | 1985 | 2014 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.4B | 3.1B |
| IPO Year | 2011 | 2020 |
Fundamental Metrics
Financial Performance| Metric | WT | RGC |
|---|---|---|
| Price | $21.87 | $10.61 |
| Analyst Decision | Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $26.33 | N/A |
| AVG Volume (30 Days) | ★ 2.1M | 291.0K |
| Earning Date | 10-30-2026 | 11-03-2026 |
| Dividend Yield | ★ 0.56% | N/A |
| EPS Growth | ★ 127.27 | N/A |
| EPS | ★ 0.14 | N/A |
| Revenue | ★ $493,753,000.00 | N/A |
| Revenue This Year | $42.27 | N/A |
| Revenue Next Year | $10.39 | N/A |
| P/E Ratio | $154.57 | ★ N/A |
| Revenue Growth | ★ 15.43 | N/A |
| 52 Week Low | $10.69 | $4.51 |
| 52 Week High | $25.91 | $69.00 |
Technical Indicators
Market Signals| Indicator | WT | RGC |
|---|---|---|
| Relative Strength Index (RSI) | 42.29 | 82.85 |
| Support Level | $21.60 | $4.97 |
| Resistance Level | $23.15 | $29.26 |
| Average True Range (ATR) | 0.73 | 1.28 |
| MACD | -0.18 | 0.36 |
| Stochastic Oscillator | 37.33 | 87.97 |
Price Performance
Historical ComparisonAbout WT WisdomTree Inc.
WisdomTree Inc is a financial innovator, offering a diverse suite of Exchange-traded products (ETPs), models and solutions, private market investments and digital asset-related products. It also offers digital products and services related to tokenized real world assets and stablecoins, including tokenized mutual funds (Digital Funds), as well as its institutional platform, WisdomTree Connect, and blockchain-native digital wallet, WisdomTree Prime. The company's products are distributed across various asset management industry channels, including banks, brokerage firms, registered investment advisers, institutional investors, private wealth managers and online brokers. The majority of the company's revenue is generated from advisory fees earned from ETPs.
About RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.